Dual Antiplatelet Therapy Post-PCI in Patients at High Bleeding Risk
In patients at high risk for bleeding after receiving a drug-eluting coronary stent, the appropriate duration of dual antiplatelet therapy to reduce the risk of ischemic complications, while minimizing bleeding risk, is unclear. New research findings are summarized in a short video.
Copyright © 2021 Massachusetts Medical Society.
